Literature DB >> 28067911

De novo mutations in SMCHD1 cause Bosma arhinia microphthalmia syndrome and abrogate nasal development.

Christopher T Gordon1,2, Shifeng Xue3,4, Gökhan Yigit5, Hicham Filali1,2,6, Kelan Chen7,8, Nadine Rosin5, Koh-Ichiro Yoshiura9, Myriam Oufadem1,2, Tamara J Beck7, Ruth McGowan10, Alex C Magee11, Janine Altmüller12,13,14, Camille Dion15, Holger Thiele12, Alexandra D Gurzau7,8, Peter Nürnberg12,14,16, Dieter Meschede17, Wolfgang Mühlbauer18, Nobuhiko Okamoto19, Vinod Varghese20, Rachel Irving20, Sabine Sigaudy21, Denise Williams22, S Faisal Ahmed23, Carine Bonnard3, Mung Kei Kong3, Ilham Ratbi6, Nawfal Fejjal24, Meriem Fikri25, Siham Chafai Elalaoui6,26, Hallvard Reigstad27, Christine Bole-Feysot2,28, Patrick Nitschké2,29, Nicola Ragge22,30, Nicolas Lévy15,21, Gökhan Tunçbilek31, Audrey S M Teo32, Michael L Cunningham33, Abdelaziz Sefiani6,26, Hülya Kayserili34, James M Murphy7,8, Chalermpong Chatdokmaiprai35, Axel M Hillmer32, Duangrurdee Wattanasirichaigoon36, Stanislas Lyonnet1,2,37, Frédérique Magdinier15, Asif Javed32, Marnie E Blewitt7,8, Jeanne Amiel1,2,37, Bernd Wollnik5,13, Bruno Reversade3,4,34,38,39.   

Abstract

Bosma arhinia microphthalmia syndrome (BAMS) is an extremely rare and striking condition characterized by complete absence of the nose with or without ocular defects. We report here that missense mutations in the epigenetic regulator SMCHD1 mapping to the extended ATPase domain of the encoded protein cause BAMS in all 14 cases studied. All mutations were de novo where parental DNA was available. Biochemical tests and in vivo assays in Xenopus laevis embryos suggest that these mutations may behave as gain-of-function alleles. This finding is in contrast to the loss-of-function mutations in SMCHD1 that have been associated with facioscapulohumeral muscular dystrophy (FSHD) type 2. Our results establish SMCHD1 as a key player in nasal development and provide biochemical insight into its enzymatic function that may be exploited for development of therapeutics for FSHD.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28067911     DOI: 10.1038/ng.3765

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  34 in total

1.  Role of the Chromosome Architectural Factor SMCHD1 in X-Chromosome Inactivation, Gene Regulation, and Disease in Humans.

Authors:  Chen-Yu Wang; Harrison Brand; Natalie D Shaw; Michael E Talkowski; Jeannie T Lee
Journal:  Genetics       Date:  2019-08-16       Impact factor: 4.562

2.  SMCHD1 terminates the first embryonic genome activation event in mouse two-cell embryos and contributes to a transcriptionally repressive state.

Authors:  Meghan L Ruebel; Kailey A Vincent; Peter Z Schall; Kai Wang; Keith E Latham
Journal:  Am J Physiol Cell Physiol       Date:  2019-07-31       Impact factor: 4.249

Review 3.  Zebrafish models of orofacial clefts.

Authors:  Kaylia M Duncan; Kusumika Mukherjee; Robert A Cornell; Eric C Liao
Journal:  Dev Dyn       Date:  2017-09-25       Impact factor: 3.780

4.  SMCHD1 mutations associated with a rare muscular dystrophy can also cause isolated arhinia and Bosma arhinia microphthalmia syndrome.

Authors:  Natalie D Shaw; Harrison Brand; Zachary A Kupchinsky; Hemant Bengani; Lacey Plummer; Takako I Jones; Serkan Erdin; Kathleen A Williamson; Joe Rainger; Alexei Stortchevoi; Kaitlin Samocha; Benjamin B Currall; Donncha S Dunican; Ryan L Collins; Jason R Willer; Angela Lek; Monkol Lek; Malik Nassan; Shahrin Pereira; Tammy Kammin; Diane Lucente; Alexandra Silva; Catarina M Seabra; Colby Chiang; Yu An; Morad Ansari; Jacqueline K Rainger; Shelagh Joss; Jill Clayton Smith; Margaret F Lippincott; Sylvia S Singh; Nirav Patel; Jenny W Jing; Jennifer R Law; Nalton Ferraro; Alain Verloes; Anita Rauch; Katharina Steindl; Markus Zweier; Ianina Scheer; Daisuke Sato; Nobuhiko Okamoto; Christina Jacobsen; Jeanie Tryggestad; Steven Chernausek; Lisa A Schimmenti; Benjamin Brasseur; Claudia Cesaretti; Jose E García-Ortiz; Tatiana Pineda Buitrago; Orlando Perez Silva; Jodi D Hoffman; Wolfgang Mühlbauer; Klaus W Ruprecht; Bart L Loeys; Masato Shino; Angela M Kaindl; Chie-Hee Cho; Cynthia C Morton; Richard R Meehan; Veronica van Heyningen; Eric C Liao; Ravikumar Balasubramanian; Janet E Hall; Stephanie B Seminara; Daniel Macarthur; Steven A Moore; Koh-Ichiro Yoshiura; James F Gusella; Joseph A Marsh; John M Graham; Angela E Lin; Nicholas Katsanis; Peter L Jones; William F Crowley; Erica E Davis; David R FitzPatrick; Michael E Talkowski
Journal:  Nat Genet       Date:  2017-01-09       Impact factor: 38.330

5.  Mutations in the BAF-Complex Subunit DPF2 Are Associated with Coffin-Siris Syndrome.

Authors:  Georgia Vasileiou; Silvia Vergarajauregui; Sabine Endele; Bernt Popp; Christian Büttner; Arif B Ekici; Marion Gerard; Nuria C Bramswig; Beate Albrecht; Jill Clayton-Smith; Jenny Morton; Susan Tomkins; Karen Low; Astrid Weber; Maren Wenzel; Janine Altmüller; Yun Li; Bernd Wollnik; George Hoganson; Maria-Renée Plona; Megan T Cho; Christian T Thiel; Hermann-Josef Lüdecke; Tim M Strom; Eduardo Calpena; Andrew O M Wilkie; Dagmar Wieczorek; Felix B Engel; André Reis
Journal:  Am J Hum Genet       Date:  2018-02-08       Impact factor: 11.025

6.  Insight Into the Ontogeny of GnRH Neurons From Patients Born Without a Nose.

Authors:  Angela Delaney; Rita Volochayev; Brooke Meader; Janice Lee; Konstantinia Almpani; Germaine Y Noukelak; Jennifer Henkind; Laura Chalmers; Jennifer R Law; Kathleen A Williamson; Christina M Jacobsen; Tatiana Pineda Buitrago; Orlando Perez; Chie-Hee Cho; Angela Kaindl; Anita Rauch; Katharina Steindl; Jose Elias Garcia; Bianca E Russell; Rameshwar Prasad; Uttam K Mondal; Hallvard M Reigstad; Scott Clements; Susan Kim; Kaoru Inoue; Gazal Arora; Kathryn B Salnikov; Nicole P DiOrio; Rolando Prada; Yline Capri; Kosuke Morioka; Michiyo Mizota; Roseli M Zechi-Ceide; Nancy M Kokitsu-Nakata; Cristiano Tonello; Siulan Vendramini-Pittoli; Gisele da Silva Dalben; Ravikumar Balasubramanian; Andrew A Dwyer; Stephanie B Seminara; William F Crowley; Lacey Plummer; Janet E Hall; John M Graham; Angela E Lin; Natalie D Shaw
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

7.  Smchd1 is a maternal effect gene required for genomic imprinting.

Authors:  Iromi Wanigasuriya; Quentin Gouil; Sarah A Kinkel; Andrés Tapia Del Fierro; Tamara Beck; Ellise A Roper; Kelsey Breslin; Jessica Stringer; Karla Hutt; Heather J Lee; Andrew Keniry; Matthew E Ritchie; Marnie E Blewitt
Journal:  Elife       Date:  2020-11-13       Impact factor: 8.140

8.  SMCHD1 mutation spectrum for facioscapulohumeral muscular dystrophy type 2 (FSHD2) and Bosma arhinia microphthalmia syndrome (BAMS) reveals disease-specific localisation of variants in the ATPase domain.

Authors:  Richard J L F Lemmers; Nienke van der Stoep; Patrick J van der Vliet; Steven A Moore; David San Leon Granado; Katherine Johnson; Ana Topf; Volker Straub; Teresinha Evangelista; Tahseen Mozaffar; Virginia Kimonis; Natalie D Shaw; Rita Selvatici; Alessandra Ferlini; Nicol Voermans; Baziel van Engelen; Sabrina Sacconi; Rabi Tawil; Meindert Lamers; Silvère M van der Maarel
Journal:  J Med Genet       Date:  2019-06-26       Impact factor: 6.318

9.  Novel key roles for structural maintenance of chromosome flexible domain containing 1 (Smchd1) during preimplantation mouse development.

Authors:  Uros Midic; Kailey A Vincent; Kai Wang; Alyson Lokken; Ashley L Severance; Amy Ralston; Jason G Knott; Keith E Latham
Journal:  Mol Reprod Dev       Date:  2018-07       Impact factor: 2.609

Review 10.  Genetics of anophthalmia and microphthalmia. Part 2: Syndromes associated with anophthalmia-microphthalmia.

Authors:  Anne Slavotinek
Journal:  Hum Genet       Date:  2018-10-30       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.